Barney BalmforthCo Founder

United Kingdom - Greater Cambridge Area

Genomics and precision medicine hold the power to transform the way we detect, diagnose, and treat disease. My passion is to ensure these benefits reach as many patients as possible around the world.

I am now leading the cancer diagnostics company Biofidelity, which has developed a revolutionary approach to the detection of mutated DNA in patient samples, offering the potential for many more patients to access the information needed to ensure the best possible treatment.

Biofidelity's ASPYRE technology is able to detect comprehensive panels of genomic biomarkers with vastly improved specificity over PCR, using standard laboratory instrumentation and at a fraction of the cost of DNA sequencing. Harnessing this technology, we are working to enable broad access to the highest precision cancer diagnostics, ensuring every patient can be prescribed the right treatment at the right time.